BRA评分在胸肌前组织扩张器乳房再造中的效用评估
BRA评分预测平均风险13.0%(7.5-41.5%),实际30天并发症发生率为31.2%(77例),但仅36例(14.6%)发生模型涵盖的并发症。模型拟合良好(Hosmer-Lemeshow 0.7167)但区分度差(C统计量<0.60),且最常见早期并发症皮肤坏死未被纳入模型。
要点
- BRA评分在胸肌前乳房再造中区分度差(C统计量<0.60),预测价值有限。
- 实际30天并发症率31.2%,远高于模型预测均值13.0%。
- 皮肤坏死是最常见早期并发症,但未被现行BRA评分模型纳入。
核心结论
- 现行30天BRA评分模型在胸肌前乳房再造中预测价值可能较差,用于患者评估和咨询辅助时应谨慎。
主要发现
- BRA评分预测30天并发症平均风险13.0%(7.5-41.5%),实际30天并发症发生率31.2%(77例)。
- 仅36例(14.6%)发生BRA评分模型涵盖的并发症,其余患者仅发生皮肤坏死或血肿。
- 模型整体拟合良好(Hosmer-Lemeshow 0.7167),但区分度差(C统计量<0.60)。
- 本研究中半数30天术后并发症为皮肤坏死,该并发症未被现行BRA评分模型纳入。
临床怎么用
- 在胸肌前乳房再造的患者评估与咨询中,不宜单独依赖BRA评分预测30天并发症风险。
局限性
- 回顾性研究设计,仅纳入两家机构,样本量247例,随访限于术后30天。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Individualized postsurgical risk assessment models provide surgeons and patients with information that is vital to the surgical decision-making process. One such tool, the Breast Reconstruction Risk Assessment (BRA) score, uses a limited selection of patient-specific factors to predict 30-day postsurgical risk of surgical site infection, seroma, dehiscence, reoperation and explantation associated with immediate submuscular tissue expander breast reconstruction. This model's performance in prepectoral tissue expander reconstruction has not been previously reported. Here, we evaluate the performance of the BRA score model in a population of patients who underwent immediate prepectoral tissue expander breast reconstruction. MATERIALS AND METHODS: A retrospective chart review was conducted of prepectoral breast reconstructions performed in 2 institutions between January 2017 and December 2018. Complications occurring within 30 days postoperatively were documented and compared with the BRA score predicted risk for each patient. RESULTS: Overall 247 patients (average age, 49.2 years) were included in the study. The mean BRA score predicted 30-day risk of a complication was 13.0% (7.5-41.5%). The observed rate of 30-day postoperative complications was 31.2% (77 patients), though only 36 (14.6%) patients had complications included in the model. The remaining patients experienced skin necrosis or hematoma as their only early complication. The 30-day BRA score model demonstrated good fit for the overall occurrence of any of the BRA score predicted complications (Hosmer-Lemeshow 0.7167), though the model discrimination was poor (C statistic <0.60). Notably, half of the 30-day postsurgical complications observed in this study were due to skin necrosis, a complication not currently included in the 30-day BRA score model. CONCLUSIONS: Our results indicate that the current 30-day BRA score model may have poor predictive value in prepectoral breast reconstruction. The most common early complication observed, skin necrosis, is not currently included in the model, suggesting that caution should be applied when using this risk predictive calculator as an adjunct to patient evaluation and counseling.
引用
- Martin S, Turner E, Nguyen A, et al. An Evaluation of the Utility of the Breast Reconstruction Risk Assessment Score Risk Model in Prepectoral Tissue Expander Breast Reconstruction. Ann Plast Surg. 2020. PMID: 32187065. doi:10.1097/SAP.0000000000002320
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。